Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

NULL
   
  • Closing Price Chg:
      18.00p
  • 52 Week High: NULL
  • 52 Week Low: 233.00p
  • Currency: UK Pounds
  • Shares Issued: 106.14m
  • Volume: 0
  • RiskGrade: 125
  • Beta: 0.02

Latest Deals

Traded Action Notifier PriceAmountValue
17-Jun-25 Buy Heather Preston 324.00p 11,389 £36,900.36

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
17-Jun-25 Buy Heather Preston 324.00p 11,389 £36,900.36

Director Shareholdings

Notifier Holding Value*
Roch Doliveux 309,808 £0
Heather Preston 29,687 £0
Frank Mathias 20,000 £0
Namrata P Patel 9,170 £0
Dame Kay Davies 1,000 £0

Major Shareholders

Notifier** Holding Value*
Briarwood Chase Management LLC 13,851,927 £0
Novo Nordisk Foundation 12,048,802 £0
Institut Merieux SA 11,510,481 £0
Briarwood Chase Management LLC 11,171,966 £0
VULPES LIFE SCIENCES FUND 8,447,390 £0
Liontrust Asset Management 6,078,799 £0
M&G Plc 5,872,847 £0
Legal & General Group Plc 5,760,126 £0
HSBC Global Custody Nominee (UK) Ltd 4,700,000 £0
Ameriprise Financial, Inc. 4,108,146 £0
Columbia Threadneedle Investments (London) 3,834,977 £0
Canaccord Genuity Group Inc 3,699,438 £0
Hargreaves Lansdown Asset Management 3,475,237 £0
SERUM LIFE SCIENCES LTD 3,382,950 £0
Nine Ten Capital 3,117,228 £0
Lansdowne Partners (London) 3,085,765 £0
Mr. S Shah 2,898,750 £0
Artisan Partners 2,620,800 £0
Cubana Investments Limited 2,506,000 £0
Interactive Investor Sharedealing 2,372,412 £0
TDWaterhouse 852,076 £0
Self Trade Stockbrokers 657,039 £0

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 18.00p
% Change 0.00 %
52 Week High NULL
52 Week Low 233.00p
Volume 0
Shares Issued 106.14m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.44% below the market average32.44% below the market average32.44% below the market average32.44% below the market average32.44% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
53.87% above the market average53.87% above the market average53.87% above the market average53.87% above the market average53.87% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Income Not Available
Growth
4.65% above the market average4.65% above the market average4.65% above the market average4.65% above the market average4.65% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page